title: [Pharmaceutical therapy of breast cancer].
authors.affiliation: Országos Onkológiai Intézet, Budapest.
authors.forename: István
authors.initials: I
authors.lastname: Láng
authors.forename: Zsuzsanna
authors.initials: Z
authors.lastname: Kahán
authors.forename: Tamás
authors.initials: T
authors.lastname: Pintér
authors.forename: Magdolna
authors.initials: M
authors.lastname: Dank
authors.forename: Katalin
authors.initials: K
authors.lastname: Boér
authors.forename: Gábor
authors.initials: G
authors.lastname: Pajkos
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Faluhelyi
authors.forename: Béla
authors.initials: B
authors.lastname: Pikó
authors.forename: Sándor
authors.initials: S
authors.lastname: Eckhardt
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Horváth
mesh_terms: D000740:Anemia / Q000139:chemically induced / Q000628:therapy; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D002100:Cachexia / Q000209:etiology / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009367:Neoplasm Staging; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
chemical_list: D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human